Novel Polymeric Gemcitabine Derivatie For Cancer Treatment: Poly-L-Glutamic Acid-Gemcitabine

1. Technology Overview

The present invention relates to a novel polymeric gemcitabine derivative for cancer treatment wheein the conjugation of gemcitabine (G) to a water-soluble polymer, poly-L-glutamic acid (PG) to yield a novel gemcitabine derivative i.e. poly-L-g;utamic acid-gemcitabine (PG-G)

  • UMCIC File Number: 628/75
  • Patent: MY-157802-A
  • Patent status: Granted
  • Malaysia patent: Novel Polymeric Gemcitabine Derivative  For Cancer Treatment: Poly-L-Glutamic Acid-Gemcitabine
  • This technology is currently available for licensing and commercialisation.